Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 23.22 USD -0.85% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Bicycle Therapeutics PLC?
Write Note

Bicycle Therapeutics PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bicycle Therapeutics PLC
Revenue Peer Comparison

Comparables:
CNTA
EXAI
AUTL
IMCR
GNS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Bicycle Therapeutics PLC
NASDAQ:BCYC
Revenue
$36.9m
CAGR 3-Years
46%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Revenue
$6.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Revenue
ÂŁ20.1m
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Revenue
$1.7m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Revenue
ÂŁ249.4m
CAGR 3-Years
102%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Revenue
ÂŁ668.8m
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
6%

See Also

What is Bicycle Therapeutics PLC's Revenue?
Revenue
36.9m USD

Based on the financial report for Sep 30, 2024, Bicycle Therapeutics PLC's Revenue amounts to 36.9m USD.

What is Bicycle Therapeutics PLC's Revenue growth rate?
Revenue CAGR 5Y
31%

Over the last year, the Revenue growth was 49%. The average annual Revenue growth rates for Bicycle Therapeutics PLC have been 46% over the past three years , 31% over the past five years .

Back to Top